The Nobel Prize-winning technology CRISPR gives us the real possibility of editing the DNA of human embryos to tackle hereditary disease. But it also raises questions of where we should draw the line, and who has a say.

Join the University of Cambridge to hear the outcomes of the UK’s first citizens’ jury on genome editing – and how we can work together to address the hopes and fears surrounding the implications of this cutting-edge science.

The event will be offered both in person and via Zoom. “Virtual tickets” cost £10 per person.